Endurant Capital Management LP - Q2 2016 holdings

$299 Million is the total value of Endurant Capital Management LP's 88 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 39.5% .

 Value Shares↓ Weighting
AGN BuyALLERGAN PLC$16,893,000
+129.2%
73,100
+165.8%
5.65%
+136.5%
SHPG BuySHIRE PLCsponsored adr$14,431,000
+111.2%
78,396
+97.2%
4.82%
+117.9%
MNKKQ BuyMALLINCKRODT PUB LTD CO$14,267,000
+0.7%
234,729
+1.5%
4.77%
+3.9%
HLS BuyHEALTHSOUTH CORP$14,228,000
+3.4%
366,513
+0.2%
4.76%
+6.7%
MCK BuyMCKESSON CORP$13,185,000
+93.4%
70,638
+63.0%
4.41%
+99.6%
ABT BuyABBOTT LABS$12,088,000
+1339.0%
307,502
+1431.1%
4.04%
+1385.7%
TEVA SellTEVA PHARMACEUTICAL INDS LTDadr$11,580,000
-33.4%
230,533
-29.0%
3.87%
-31.3%
AET SellAETNA INC NEW$11,494,000
+7.5%
94,115
-1.2%
3.84%
+10.9%
WMGI BuyWRIGHT MED GROUP N V$9,936,000
+426.8%
572,028
+403.4%
3.32%
+443.5%
STJ SellST JUDE MED INC$9,460,000
+17.9%
121,282
-16.9%
3.16%
+21.7%
BSX SellBOSTON SCIENTIFIC CORP$8,577,000
-13.4%
366,998
-30.3%
2.87%
-10.7%
TMO SellTHERMO FISHER SCIENTIFIC INC$7,637,000
+0.8%
51,686
-3.4%
2.55%
+4.1%
CNC BuyCENTENE CORP DEL$7,282,000
+56.0%
102,038
+34.5%
2.43%
+60.9%
UNH SellUNITEDHEALTH GROUP INC$7,146,000
-20.2%
50,606
-27.2%
2.39%
-17.7%
WBA SellWALGREENS BOOTS ALLIANCE INC$6,521,000
-27.3%
78,314
-26.5%
2.18%
-25.0%
LH BuyLABORATORY CORP AMER HLDGS$6,176,000
+30.5%
47,412
+17.3%
2.06%
+34.6%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$5,888,000
+12.6%
43,907
+4.8%
1.97%
+16.2%
HOLX BuyHOLOGIC INC$5,820,000
+173.4%
168,208
+172.6%
1.94%
+181.9%
SYK SellSTRYKER CORP$5,328,000
-27.4%
44,465
-35.0%
1.78%
-25.0%
BIIB SellBIOGEN INC$4,965,000
-41.7%
20,532
-37.3%
1.66%
-39.9%
BDX SellBECTON DICKINSON & CO$4,962,000
-27.3%
29,259
-34.9%
1.66%
-25.0%
SPNC SellSPECTRANETICS CORP$4,558,000
-27.5%
243,626
-43.7%
1.52%
-25.1%
 FLUIDIGM CORP DELnote 2.750% 2/0$4,357,000
+10.1%
7,261,0000.0%1.46%
+13.6%
DVA BuyDAVITA HEALTHCARE PARTNERS I$4,167,000
+39.2%
53,889
+32.1%
1.39%
+43.6%
A SellAGILENT TECHNOLOGIES INC$4,014,000
+10.8%
90,485
-0.4%
1.34%
+14.4%
AMGN BuyAMGEN INC$4,002,000
+376.4%
26,300
+369.6%
1.34%
+391.9%
ABC NewAMERISOURCEBERGEN CORP$3,855,00048,600
+100.0%
1.29%
ZBH SellZIMMER BIOMET HLDGS INC$3,756,000
-62.0%
31,205
-66.3%
1.26%
-60.8%
CRL BuyCHARLES RIV LABS INTL INC$3,305,000
+299.6%
40,088
+268.2%
1.10%
+312.3%
ANTM SellANTHEM INC$3,304,000
-45.5%
25,154
-42.3%
1.10%
-43.8%
LHCG NewLHC GROUP INC$3,125,00072,200
+100.0%
1.04%
NVRO SellNEVRO CORP$3,060,000
+11.6%
41,484
-14.9%
1.02%
+15.1%
JNJ NewJOHNSON & JOHNSON$2,972,00024,500
+100.0%
0.99%
NSTG BuyNANOSTRING TECHNOLOGIES INC$2,614,000
+46.1%
207,468
+76.5%
0.87%
+50.7%
VWR SellVWR CORP$2,372,000
-43.6%
82,089
-47.2%
0.79%
-41.8%
GILD SellGILEAD SCIENCES INC$2,320,000
-62.8%
27,810
-59.0%
0.78%
-61.6%
STE NewSTERIS PLC$2,317,00033,700
+100.0%
0.77%
FLDM SellFLUIDIGM CORP DEL$2,316,000
-47.2%
256,490
-52.8%
0.77%
-45.5%
SRCL NewSTERICYCLE INC$2,311,00022,200
+100.0%
0.77%
CELG BuyCELGENE CORP$2,257,000
+57.9%
22,880
+60.2%
0.75%
+62.9%
ESRX SellEXPRESS SCRIPTS HLDG CO$2,102,000
-41.3%
27,727
-46.8%
0.70%
-39.4%
BKD SellBROOKDALE SR LIVING INC$1,963,000
-32.7%
127,120
-30.8%
0.66%
-30.6%
NTUS NewNATUS MEDICAL INC DEL$1,830,00048,400
+100.0%
0.61%
HRC SellHILL ROM HLDGS INC$1,796,000
-81.9%
35,600
-82.0%
0.60%
-81.3%
TNDM BuyTANDEM DIABETES CARE INC$1,739,000
+7.6%
230,671
+24.3%
0.58%
+10.9%
AMAG SellAMAG PHARMACEUTICALS INC$1,731,000
-72.1%
72,380
-72.7%
0.58%
-71.2%
BBH NewVANECK VECTORS ETF TRbiotech etf$1,668,00016,300
+100.0%
0.56%
MYL SellMYLAN N V$1,623,000
-42.8%
37,524
-38.7%
0.54%
-40.9%
MD NewMEDNAX INC$1,231,00017,000
+100.0%
0.41%
FVE SellFIVE STAR QUALITY CARE INC$1,151,000
-25.3%
492,089
-26.8%
0.38%
-22.8%
EVHC SellENVISION HEALTHCARE HLDGS IN$1,145,000
-84.3%
45,149
-87.4%
0.38%
-83.8%
PFE SellPFIZER INC$1,130,000
-72.7%
32,100
-77.0%
0.38%
-71.8%
CVS BuyCVS HEALTH CORP$1,090,000
+23.6%
11,385
+33.9%
0.36%
+27.3%
HCA SellHCA HOLDINGS INC$1,071,000
-83.3%
13,911
-83.1%
0.36%
-82.8%
PEN SellPENUMBRA INC$1,006,000
-11.4%
16,900
-31.6%
0.34%
-8.7%
CTLT NewCATALENT INC$929,00040,400
+100.0%
0.31%
HZNP SellHORIZON PHARMA PLC$930,000
-43.2%
56,440
-42.9%
0.31%
-41.4%
BAX NewBAXTER INTL INC$900,00019,909
+100.0%
0.30%
WAT NewWATERS CORP$872,0006,200
+100.0%
0.29%
GI BuyENDOCHOICE HLDGS INC$829,000
+21.7%
169,163
+29.4%
0.28%
+25.3%
SSRG BuySYMMETRY SURGICAL INC$812,000
+73.9%
61,819
+30.6%
0.27%
+79.5%
VRX BuyVALEANT PHARMACEUTICALS INTL$808,000
+127.6%
40,100
+197.0%
0.27%
+134.8%
AMPH SellAMPHASTAR PHARMACEUTICALS IN$787,000
-53.2%
48,825
-65.2%
0.26%
-51.7%
DERM BuyDERMIRA INC$766,000
+180.6%
26,188
+98.6%
0.26%
+190.9%
PARNF BuyPARNELL PHARMACEUT HLDGS LTD$732,000
-10.9%
448,802
+16.3%
0.24%
-7.9%
NLNK NewNEWLINK GENETICS CORP$704,00062,491
+100.0%
0.24%
HWAY BuyHEALTHWAYS INC$693,000
+34.0%
60,016
+17.2%
0.23%
+38.9%
PRGO BuyPERRIGO CO PLC$689,000
+49.5%
7,600
+111.1%
0.23%
+54.4%
INCY BuyINCYTE CORP$664,000
+17.5%
8,300
+6.4%
0.22%
+21.3%
NBIX BuyNEUROCRINE BIOSCIENCES INC$641,000
+23.7%
14,100
+7.6%
0.21%
+27.4%
AERI SellAERIE PHARMACEUTICALS INC$588,000
+12.0%
33,400
-22.7%
0.20%
+15.9%
ILMN SellILLUMINA INC$543,000
-70.4%
3,870
-65.8%
0.18%
-69.3%
VRTX SellVERTEX PHARMACEUTICALS INC$538,000
-22.7%
6,250
-28.6%
0.18%
-20.0%
CI BuyCIGNA CORPORATION$523,000
+104.3%
4,089
+119.1%
0.18%
+110.8%
RAD SellRITE AID CORP$454,000
-54.4%
60,600
-50.4%
0.15%
-52.8%
MTD NewMETTLER TOLEDO INTERNATIONAL$401,0001,100
+100.0%
0.13%
BCR SellBARD C R INC$380,000
-80.3%
1,618
-83.0%
0.13%
-79.6%
PCRX NewPACIRA PHARMACEUTICALS INC$354,00010,500
+100.0%
0.12%
HUM SellHUMANA INC$323,000
-54.7%
1,798
-53.9%
0.11%
-53.2%
CSLT SellCASTLIGHT HEALTH INCcl b$307,000
-27.8%
77,558
-39.2%
0.10%
-25.4%
NVLS BuyNIVALIS THERAPEUTICS INC$303,000
+134.9%
65,783
+112.3%
0.10%
+140.5%
RDUS NewRADIUS HEALTH INC$301,0008,200
+100.0%
0.10%
ARA NewAMERICAN RENAL ASSOCIATES HO$246,0008,500
+100.0%
0.08%
BuyTRILLIUM THERAPEUTICS INC$245,000
+111.2%
27,300
+118.4%
0.08%
+115.8%
ALDR NewALDER BIOPHARMACEUTICALS INC$245,0009,800
+100.0%
0.08%
PMC SellPHARMERICA CORP$232,000
-89.5%
9,390
-90.6%
0.08%
-89.1%
OCRX SellOCERA THERAPEUTICS INC$196,000
-51.4%
103,142
-24.8%
0.07%
-49.6%
RXDX NewIGNYTA INC$109,00020,200
+100.0%
0.04%
XENT ExitINTERSECT ENT INC$0-12,000
-100.0%
-0.07%
ZLTQ ExitZELTIQ AESTHETICS INC$0-9,100
-100.0%
-0.08%
WOOF ExitVCA INC$0-6,300
-100.0%
-0.12%
DPLO ExitDIPLOMAT PHARMACY INC$0-13,800
-100.0%
-0.12%
ABBV ExitABBVIE INC$0-6,700
-100.0%
-0.12%
NXTM ExitNXSTAGE MEDICAL INC$0-26,400
-100.0%
-0.13%
CAH ExitCARDINAL HEALTH INC$0-5,200
-100.0%
-0.14%
ONCE ExitSPARK THERAPEUTICS INC$0-17,500
-100.0%
-0.17%
MRK ExitMERCK & CO INC NEW$0-10,105
-100.0%
-0.17%
MDVN ExitMEDIVATION INC$0-23,100
-100.0%
-0.34%
CNMD ExitCONMED CORP$0-28,090
-100.0%
-0.38%
GMED ExitGLOBUS MED INCcl a$0-65,700
-100.0%
-0.50%
KTWO ExitK2M GROUP HLDGS INC$0-127,300
-100.0%
-0.61%
KMPH ExitKEMPHARM INC$0-169,586
-100.0%
-0.80%
MDT ExitMEDTRONIC PLC$0-71,866
-100.0%
-1.75%
BXLT ExitBAXALTA INC$0-175,225
-100.0%
-2.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings